APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nucleic Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nucleic Vaccine Industry Growth and Trends Forecast to 2032

23 December 2025100 pages

Choose your research edition.

Industry ResearchNucleic Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Nucleic Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Nucleic Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nucleic Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nucleic Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nucleic Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nucleic Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nucleic Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nucleic Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nucleic Vaccine include CNBG, Zhifei Shengwu, Walvax Biotechnology, Sanofi, Liaoning Chengda, CanSinoBIO, BioKangtai, Hualan Bio and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nucleic Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nucleic Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nucleic Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nucleic Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nucleic Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nucleic Vaccine Market by Company

CNBG

Zhifei Shengwu

Walvax Biotechnology

Sanofi

Liaoning Chengda

CanSinoBIO

BioKangtai

Hualan Bio

GSK

Fosun Pharma

Moderna

Inovio

CureVac

Nucleic Vaccine Segment by Type

Preventive Nucleic Vaccine

Therapeutic Nucleic Vaccine

Nucleic Vaccine Segment by Application

Hospital

Clinic

Others

Nucleic Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nucleic Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nucleic Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nucleic Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nucleic Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nucleic Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Preventive Nucleic Vaccine Table 2. Major Company of Therapeutic Nucleic Vaccine Table 3. Global Nucleic Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nucleic Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Nucleic Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nucleic Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nucleic Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Nucleic Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Nucleic Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Nucleic Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nucleic Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nucleic Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Nucleic Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Nucleic Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Nucleic Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nucleic Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Nucleic Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nucleic Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Nucleic Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nucleic Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Nucleic Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nucleic Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Nucleic Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Nucleic Vaccine Industry Trends Table 25. Nucleic Vaccine Industry Drivers Table 26. Nucleic Vaccine Industry Opportunities and Challenges Table 27. Nucleic Vaccine Industry Restraints Table 28. Global Nucleic Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nucleic Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Nucleic Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Nucleic Vaccine Sales Share by Company (2021-2026) Table 32. Global Nucleic Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Nucleic Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nucleic Vaccine Major Company Production Sites and Headquarters Table 35. Global Nucleic Vaccine Company, Product Type & Application Table 36. Global Nucleic Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nucleic Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nucleic Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nucleic Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Nucleic Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nucleic Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nucleic Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Nucleic Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Nucleic Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Nucleic Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nucleic Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nucleic Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Nucleic Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Nucleic Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nucleic Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Nucleic Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nucleic Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nucleic Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Nucleic Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Nucleic Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Nucleic Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nucleic Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nucleic Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Nucleic Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Nucleic Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Nucleic Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nucleic Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Nucleic Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nucleic Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Nucleic Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nucleic Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Nucleic Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nucleic Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Nucleic Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. CNBG Company Information Table 72. CNBG Business Overview Table 73. CNBG Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. CNBG Nucleic Vaccine Product Portfolio Table 75. CNBG Recent Development Table 76. Zhifei Shengwu Company Information Table 77. Zhifei Shengwu Business Overview Table 78. Zhifei Shengwu Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Zhifei Shengwu Nucleic Vaccine Product Portfolio Table 80. Zhifei Shengwu Recent Development Table 81. Walvax Biotechnology Company Information Table 82. Walvax Biotechnology Business Overview Table 83. Walvax Biotechnology Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Walvax Biotechnology Nucleic Vaccine Product Portfolio Table 85. Walvax Biotechnology Recent Development Table 86. Sanofi Company Information Table 87. Sanofi Business Overview Table 88. Sanofi Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Sanofi Nucleic Vaccine Product Portfolio Table 90. Sanofi Recent Development Table 91. Liaoning Chengda Company Information Table 92. Liaoning Chengda Business Overview Table 93. Liaoning Chengda Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Liaoning Chengda Nucleic Vaccine Product Portfolio Table 95. Liaoning Chengda Recent Development Table 96. CanSinoBIO Company Information Table 97. CanSinoBIO Business Overview Table 98. CanSinoBIO Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. CanSinoBIO Nucleic Vaccine Product Portfolio Table 100. CanSinoBIO Recent Development Table 101. BioKangtai Company Information Table 102. BioKangtai Business Overview Table 103. BioKangtai Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. BioKangtai Nucleic Vaccine Product Portfolio Table 105. BioKangtai Recent Development Table 106. Hualan Bio Company Information Table 107. Hualan Bio Business Overview Table 108. Hualan Bio Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Hualan Bio Nucleic Vaccine Product Portfolio Table 110. Hualan Bio Recent Development Table 111. GSK Company Information Table 112. GSK Business Overview Table 113. GSK Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. GSK Nucleic Vaccine Product Portfolio Table 115. GSK Recent Development Table 116. Fosun Pharma Company Information Table 117. Fosun Pharma Business Overview Table 118. Fosun Pharma Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Fosun Pharma Nucleic Vaccine Product Portfolio Table 120. Fosun Pharma Recent Development Table 121. Moderna Company Information Table 122. Moderna Business Overview Table 123. Moderna Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Moderna Nucleic Vaccine Product Portfolio Table 125. Moderna Recent Development Table 126. Inovio Company Information Table 127. Inovio Business Overview Table 128. Inovio Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Inovio Nucleic Vaccine Product Portfolio Table 130. Inovio Recent Development Table 131. CureVac Company Information Table 132. CureVac Business Overview Table 133. CureVac Nucleic Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. CureVac Nucleic Vaccine Product Portfolio Table 135. CureVac Recent Development Table 136. North America Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America Nucleic Vaccine Sales by Country (2021-2026) & (k units) Table 138. North America Nucleic Vaccine Sales Market Share by Country (2021-2026) Table 139. North America Nucleic Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. North America Nucleic Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. North America Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Nucleic Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Nucleic Vaccine Market Share by Country (2021-2026) Table 144. North America Nucleic Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Nucleic Vaccine Market Share Forecast by Country (2027-2032) Table 146. Europe Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe Nucleic Vaccine Sales by Country (2021-2026) & (k units) Table 148. Europe Nucleic Vaccine Sales Market Share by Country (2021-2026) Table 149. Europe Nucleic Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe Nucleic Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Nucleic Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Nucleic Vaccine Market Share by Country (2021-2026) Table 154. Europe Nucleic Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Nucleic Vaccine Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Nucleic Vaccine Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific Nucleic Vaccine Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Nucleic Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific Nucleic Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Nucleic Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Nucleic Vaccine Market Share by Country (2021-2026) Table 164. Asia-Pacific Nucleic Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Nucleic Vaccine Market Share Forecast by Country (2027-2032) Table 166. Latin America Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America Nucleic Vaccine Sales by Country (2021-2026) & (k units) Table 168. Latin America Nucleic Vaccine Sales Market Share by Country (2021-2026) Table 169. Latin America Nucleic Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America Nucleic Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Nucleic Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Nucleic Vaccine Market Share by Country (2021-2026) Table 174. Latin America Nucleic Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Nucleic Vaccine Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Nucleic Vaccine Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa Nucleic Vaccine Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Nucleic Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa Nucleic Vaccine Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Nucleic Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Nucleic Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Nucleic Vaccine Market Share by Country (2021-2026) Table 184. Middle East and Africa Nucleic Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Nucleic Vaccine Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Nucleic Vaccine Distributors List Table 189. Nucleic Vaccine Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Nucleic Vaccine Image Figure 2. Global Nucleic Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nucleic Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Nucleic Vaccine Sales (2021-2032) & (k units) Figure 5. Preventive Nucleic Vaccine Image Figure 6. Global Preventive Nucleic Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 7. Therapeutic Nucleic Vaccine Image Figure 8. Global Therapeutic Nucleic Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Nucleic Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nucleic Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Nucleic Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Nucleic Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Nucleic Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nucleic Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nucleic Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nucleic Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nucleic Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Nucleic Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Nucleic Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Nucleic Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Nucleic Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Nucleic Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Nucleic Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Nucleic Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Nucleic Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Nucleic Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Nucleic Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Nucleic Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Nucleic Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nucleic Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Nucleic Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nucleic Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Nucleic Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Nucleic Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Nucleic Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nucleic Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Nucleic Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nucleic Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Nucleic Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nucleic Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Nucleic Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Nucleic Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Nucleic Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nucleic Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Nucleic Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Nucleic Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Nucleic Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Preventive Nucleic Vaccine
  • Therapeutic Nucleic Vaccine
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • CNBG
  • Zhifei Shengwu
  • Walvax Biotechnology
  • Sanofi
  • Liaoning Chengda
  • CanSinoBIO
  • BioKangtai
  • Hualan Bio
  • GSK
  • Fosun Pharma
  • Moderna
  • Inovio
  • CureVac

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nucleic Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nucleic Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nucleic Vaccine Market by Type
  6. 1.3.1 Preventive Nucleic Vaccine
  7. 1.3.2 Therapeutic Nucleic Vaccine
  8. 1.4 Global Nucleic Vaccine Market Size by Type
  9. 1.4.1 Global Nucleic Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nucleic Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nucleic Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nucleic Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nucleic Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nucleic Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nucleic Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nucleic Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nucleic Vaccine Industry Trends
  2. 2.2 Nucleic Vaccine Industry Drivers
  3. 2.3 Nucleic Vaccine Industry Opportunities and Challenges
  4. 2.4 Nucleic Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nucleic Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Nucleic Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Nucleic Vaccine Price (2021-2026)
  4. 3.4 Global Nucleic Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nucleic Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Nucleic Vaccine Company, Product Type & Application
  7. 3.7 Global Nucleic Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nucleic Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nucleic Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nucleic Vaccine Tier 1, Tier 2, and Tier 3
4 Nucleic Vaccine Regional Status and Outlook
  1. 4.1 Global Nucleic Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nucleic Vaccine Historic Market Size by Region
  3. 4.2.1 Global Nucleic Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nucleic Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nucleic Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nucleic Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Nucleic Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nucleic Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nucleic Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nucleic Vaccine by Application
  1. 5.1 Nucleic Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Nucleic Vaccine Market Size by Application
  6. 5.2.1 Global Nucleic Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Nucleic Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Nucleic Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Nucleic Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Nucleic Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Nucleic Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Nucleic Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Nucleic Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CNBG
  2. 6.1.1 CNBG Company Information
  3. 6.1.2 CNBG Business Overview
  4. 6.1.3 CNBG Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CNBG Nucleic Vaccine Product Portfolio
  6. 6.1.5 CNBG Recent Developments
  7. 6.2 Zhifei Shengwu
  8. 6.2.1 Zhifei Shengwu Company Information
  9. 6.2.2 Zhifei Shengwu Business Overview
  10. 6.2.3 Zhifei Shengwu Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zhifei Shengwu Nucleic Vaccine Product Portfolio
  12. 6.2.5 Zhifei Shengwu Recent Developments
  13. 6.3 Walvax Biotechnology
  14. 6.3.1 Walvax Biotechnology Company Information
  15. 6.3.2 Walvax Biotechnology Business Overview
  16. 6.3.3 Walvax Biotechnology Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Walvax Biotechnology Nucleic Vaccine Product Portfolio
  18. 6.3.5 Walvax Biotechnology Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Nucleic Vaccine Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Liaoning Chengda
  26. 6.5.1 Liaoning Chengda Company Information
  27. 6.5.2 Liaoning Chengda Business Overview
  28. 6.5.3 Liaoning Chengda Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Liaoning Chengda Nucleic Vaccine Product Portfolio
  30. 6.5.5 Liaoning Chengda Recent Developments
  31. 6.6 CanSinoBIO
  32. 6.6.1 CanSinoBIO Company Information
  33. 6.6.2 CanSinoBIO Business Overview
  34. 6.6.3 CanSinoBIO Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CanSinoBIO Nucleic Vaccine Product Portfolio
  36. 6.6.5 CanSinoBIO Recent Developments
  37. 6.7 BioKangtai
  38. 6.7.1 BioKangtai Company Information
  39. 6.7.2 BioKangtai Business Overview
  40. 6.7.3 BioKangtai Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 BioKangtai Nucleic Vaccine Product Portfolio
  42. 6.7.5 BioKangtai Recent Developments
  43. 6.8 Hualan Bio
  44. 6.8.1 Hualan Bio Company Information
  45. 6.8.2 Hualan Bio Business Overview
  46. 6.8.3 Hualan Bio Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hualan Bio Nucleic Vaccine Product Portfolio
  48. 6.8.5 Hualan Bio Recent Developments
  49. 6.9 GSK
  50. 6.9.1 GSK Company Information
  51. 6.9.2 GSK Business Overview
  52. 6.9.3 GSK Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GSK Nucleic Vaccine Product Portfolio
  54. 6.9.5 GSK Recent Developments
  55. 6.10 Fosun Pharma
  56. 6.10.1 Fosun Pharma Company Information
  57. 6.10.2 Fosun Pharma Business Overview
  58. 6.10.3 Fosun Pharma Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Fosun Pharma Nucleic Vaccine Product Portfolio
  60. 6.10.5 Fosun Pharma Recent Developments
  61. 6.11 Moderna
  62. 6.11.1 Moderna Company Information
  63. 6.11.2 Moderna Business Overview
  64. 6.11.3 Moderna Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Moderna Nucleic Vaccine Product Portfolio
  66. 6.11.5 Moderna Recent Developments
  67. 6.12 Inovio
  68. 6.12.1 Inovio Company Information
  69. 6.12.2 Inovio Business Overview
  70. 6.12.3 Inovio Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Inovio Nucleic Vaccine Product Portfolio
  72. 6.12.5 Inovio Recent Developments
  73. 6.13 CureVac
  74. 6.13.1 CureVac Company Information
  75. 6.13.2 CureVac Business Overview
  76. 6.13.3 CureVac Nucleic Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 CureVac Nucleic Vaccine Product Portfolio
  78. 6.13.5 CureVac Recent Developments
7 North America by Country
  1. 7.1 North America Nucleic Vaccine Sales by Country
  2. 7.1.1 North America Nucleic Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nucleic Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Nucleic Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nucleic Vaccine Market Size by Country
  6. 7.2.1 North America Nucleic Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nucleic Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Nucleic Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nucleic Vaccine Sales by Country
  2. 8.1.1 Europe Nucleic Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nucleic Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Nucleic Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nucleic Vaccine Market Size by Country
  6. 8.2.1 Europe Nucleic Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nucleic Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nucleic Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nucleic Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Nucleic Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nucleic Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nucleic Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nucleic Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Nucleic Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nucleic Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nucleic Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nucleic Vaccine Sales by Country
  2. 10.1.1 South America Nucleic Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nucleic Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Nucleic Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nucleic Vaccine Market Size by Country
  6. 10.2.1 South America Nucleic Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nucleic Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Nucleic Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nucleic Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Nucleic Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nucleic Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nucleic Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nucleic Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Nucleic Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nucleic Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nucleic Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nucleic Vaccine Value Chain Analysis
  2. 12.1.1 Nucleic Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nucleic Vaccine Production Mode & Process
  7. 12.2 Nucleic Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nucleic Vaccine Distributors
  10. 12.2.3 Nucleic Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst